Hey there, curious minds!
Want to know what’s buzzing in the world of GPCRs? Join us for this week’s update, where you’ll find all the latest breakthroughs and exciting developments in GPCR research. We can’t wait to share it with you!
This Week’s Highlights:
🤩 Seriously, why would you want to miss out on all the awesomeness that comes with a DrGPCR Premium Membership?
As a premium member, you have access to all the complimentary perks as well as:
Initiate a vibrant conversation or seek assistance
to keep you informed and engaged
connecting candidates with positions
Networking is crucial in professional endeavors :)
Big Update! Starting in 2025, content access to Classified GPCR News will only be reserved for Premium Members. This strategic decision to limit free content is essential as we need to increase revenue to support the community.
Prix Galien USA: Domain Therapeutics Nominated for the Prestigious Best Startup Award
AI, Synthetic Biology and Drug Discovery- with Aikium's Dr Venkatesh Mysore
Trevena teeters in dangerous territory, terminating CEO and other execs amid strategic review
Trevena Reports Third Quarter 2024 Results and Provides Business Update
NEW November 18 - 20, 2024 | 7th CB1 & CB2 Targeting Drug Development Summit
November 25 - 26, 2024 | 6th International Conference on Stem Cell, Tissue Engineering and Regenerat
November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe
February 15 - 16, 2025 | Structural and Functional Approaches in GPCR Drug Discovery
July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology
Get your 5-day free trial TODAY!
Comments